On Monday, Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) opened lower -5.61% from the last session, before settling in for the closing price of $11.22. Price fluctuations for ARCT have ranged from $8.04 to $24.17 over the past 52 weeks.
During the last 5-year period, the sales drop of Healthcare Sector giant was -6.84%. Company’s average yearly earnings per share was noted 12.05% at the time writing. With a float of $24.87 million, this company’s outstanding shares have now reached $27.15 million.
Arcturus Therapeutics Holdings Inc (ARCT) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Arcturus Therapeutics Holdings Inc is 8.42%, while institutional ownership is 95.28%.
Arcturus Therapeutics Holdings Inc (ARCT) Earnings and Forecasts
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.26 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -1.02) by 0.76. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.97 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 12.05% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 21.35% during the next five years compared to -6.84% drop over the previous five years of trading.
Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) Trading Performance Indicators
Check out the current performance indicators for Arcturus Therapeutics Holdings Inc (ARCT). In the past quarter, the stock posted a quick ratio of 5.90. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.62.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.22, a number that is poised to hit -0.90 in the next quarter and is forecasted to reach -2.66 in one year’s time.
Technical Analysis of Arcturus Therapeutics Holdings Inc (ARCT)
Looking closely at Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT), its last 5-days average volume was 5.69 million, which is a jump from its year-to-date volume of 0.66 million. As of the previous 9 days, the stock’s Stochastic %D was 13.89%.
During the past 100 days, Arcturus Therapeutics Holdings Inc’s (ARCT) raw stochastic average was set at 9.35%, which indicates a significant increase from 9.35% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.85 in the past 14 days, which was higher than the 1.25 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $18.59, while its 200-day Moving Average is $14.90. However, in the short run, Arcturus Therapeutics Holdings Inc’s stock first resistance to watch stands at $11.21. Second resistance stands at $11.82. The third major resistance level sits at $12.18. If the price goes on to break the first support level at $10.24, it is likely to go to the next support level at $9.88. Should the price break the second support level, the third support level stands at $9.27.
Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) Key Stats
There are currently 27,155K shares outstanding in the company with a market cap of 287.57 million. Presently, the company’s annual sales total 152,310 K according to its annual income of -80,940 K. Last quarter, the company’s sales amounted to 28,300 K and its income totaled -9,180 K.
